Home » News » Awards & Advancement » PRA Health Sciences appoints new director

PRA Health Sciences appoints new director

Monday, October 19, 2015

PRA Health Sciences has appointed Linda Grais, M.D. to the board of directors. Grais also will serve on the audit committee.

Grais has been a member of the board of directors of Ocera Therapeutics since January 2008 and president and chief executive officer of Ocera Therapeutics since June 2012. Previously, Grais was a managing member at InterWest Partners, a venture capital firm. Grais also was a founder and executive vice president of SGX Pharmaceuticals, a drug discovery company focusing on new treatments for cancer.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!